Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-25-000072
Filing Date
2025-05-14
Accepted
2025-05-14 07:18:24
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20250331.htm   iXBRL 10-Q 1468106
2 EX-31.1 a20250331exhibit311.htm EX-31.1 9297
3 EX-31.2 a20250331exhibit312.htm EX-31.2 9214
4 EX-32.1 a20250331exhibit321.htm EX-32.1 5252
5 EX-32.2 a20250331exhibit322.htm EX-32.2 5058
  Complete submission text file 0001847903-25-000072.txt   6760879

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20250331.xsd EX-101.SCH 38469
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20250331_cal.xml EX-101.CAL 82074
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20250331_def.xml EX-101.DEF 209403
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20250331_lab.xml EX-101.LAB 606260
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20250331_pre.xml EX-101.PRE 410693
72 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20250331_htm.xml XML 790857
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 25942637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)